Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ypsomed Holding AGYPHDF 92 Days Sales Outstanding is 80.64 as of Mar. 2026, which is 14% above its 10-year median of 70.46. GuruFocus rates YPHDF with a GF Score™ of 92/100 and a GF Value™ of $557.98. The stock has 4 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Ypsomed Holding AG ranks worse than 69.67% on this metric.
The historical rank and industry rank for Ypsomed Holding AG's Days Sales Outstanding or its related term are showing as below:
YPHDF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.54 Med: 70.46 Max: 90.09
Current: 83.7
During the past 13 years, Ypsomed Holding AG's highest Days Sales Outstanding was 90.09. The lowest was 54.54. And the median was 70.46.
YPHDF's Days Sales Outstanding is ranked worse than 69.67% of 811
companies
in the Medical Devices & Instruments industry
Industry Median: 65.38
vs YPHDF: 83.70
Ypsomed Holding AG's Days Sales Outstanding
increased
from Mar. 2025 (66.98) to Mar. 2026 (80.64).
Ypsomed Holding AG (OTCPK:YPHDF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Ypsomed Holding AG Days Sales Outstanding Related Terms
Ypsomed Holding AG Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Ypsomed Holding AG's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YPHDF vs ISRG, BDX, RMD: Days Sales Outstanding Comparison
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's Days Sales Outstanding falls into.
Ypsomed Holding AG Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ypsomed Holding AG (YPHDF) has a Days Sales Outstanding of 80.64 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ypsomed Holding AG and its competitors. This is 14% above median its historical median of 70.46. Over the past decade, Ypsomed Holding AG's Days Sales Outstanding has ranged from 54.54 to 90.09. According to the industry distribution chart, Ypsomed Holding AG ranks #565 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 69.7%.
Is Ypsomed Holding AG's Days Sales Outstanding too high?
Ypsomed Holding AG's current Days Sales Outstanding of 80.64 is 14% above median its 10-year median of 70.46. Over the past 10 years, this metric has ranged from a low of 54.54 to a high of 90.09. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.38. Ypsomed Holding AG's value of 80.64 is 23.3% above this industry median. Based on the distribution chart, Ypsomed Holding AG ranks #565 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ypsomed Holding AG has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Days Sales Outstanding compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #565 out of 811 companies for Days Sales Outstanding. This places Ypsomed Holding AG in the lower half of its industry. The industry median Days Sales Outstanding is 65.38. Ypsomed Holding AG's value of 80.64 is 23.3% above this benchmark. Historically, Ypsomed Holding AG's own Days Sales Outstanding has ranged from 54.54 to 90.09 over the past decade. While the company's 10-year median is 70.46 vs. the industry median of 65.38, Ypsomed Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.38, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ypsomed Holding AG's current Days Sales Outstanding of 80.64 is 23.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current Days Sales Outstanding is 80.64, which is 14% above median its own 10-year median of 70.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Ypsomed Holding AG (YPHDF) has a current Days Sales Outstanding of 80.64. The stock's GF Value™ is $557.98, compared to a current price of $436.55 — trading 21.8% below its estimated fair value. The current Days Sales Outstanding is 80.64, which is 14% above median its 10-year median of 70.46 and 23.3% above the Medical Devices & Instruments industry median of 65.38. Ypsomed Holding AG's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Ypsomed Holding AG (YPHDF), the current Days Sales Outstanding is 80.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (YPHDF) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued.
The current stock price of $436.55 is trading 21.8% below its estimated GF Value™ of $557.98.
Key valuation signals for YPHDF:
Days Sales Outstanding: 80.64 (14% above median its 10-year median of 70.46)
GF Value™: $557.98 vs. price of $436.55 (21.8% below fair value)
Industry Position: 23.3% above the Medical Devices & Instruments median (#565 of 811)
No single metric tells the full story. See the YPHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score
Get the complete analysis for YPHDF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YPHDF has been successfully added to your 
